Skip to main content
Top

PharmacoEconomics

Issue 3/2005

Content (9 Articles)

Editorial

EMEA: for patients or for industry?

Silvio Garattini

Current Opinion

The relationship between productivity and health-related QOL

Werner B. F. Brouwer, Willem-Jan Meerding, Leida M. Lamers, Johan L. Severens

Current Opinion

Penny and pound wise

Mike F. van Oostenbruggen, Ronald B. Jansen, Katja Mur, Huib Kooijman

Leading Article

The economic impact of neuropsychiatric symptoms in Alzheimer’s disease

Daniel L. Murman, Christopher C. Colenda

Review Article

International variation in resource utilisation and treatment costs for rheumatoid arthritis

Hubertus Rosery, Rito Bergemann, Stefanie Maxion-Bergemann

Review Article

Oral serotonin receptor agonists

Jennifer H. Lofland, David B. Nash

Original Research Article

A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain

Pedro J. Tárraga-López, Ángel Celada-Rodríguez, Miguel Cerdán-Oliver, Juan Solera-Albero, José M. Ocaña-López, Mateo A. López-Cara, Jaime De Miguel-Clave

Original Research Article

Cost-effectiveness model of long-acting risperidone in schizophrenia in the US

Natalie C. Edwards, Marcia F. T. Rupnow, Chris L. Pashos, Marc F. Botteman, Ronald J. Diamond